press release
TYSONS, Va., Sept. 09, 2022 (GLOBE NEWSWIRE) — Park Hotels & Resorts Inc. PC (“Park” or the “Company”) announced today that the Company announced...
Hi, what are you looking for?
TYSONS, Va., Sept. 09, 2022 (GLOBE NEWSWIRE) — Park Hotels & Resorts Inc. PC (“Park” or the “Company”) announced today that the Company announced...
A new report warns the Cannabis growers don’t have access to federal bankruptcy protection, “undermining” the potential of the industry. This is because marijuana...
There are several critical aspects of the PreMarket Prep Show that no other financial medium has even a clue about. One of them is...
A large overhang was raised with the FDA approval from Revance Therapeutics Inc RVNC Daxxify (Daxibotulinum toxin A-lanm). The catalyst also represents a...
US stocks were higher at the close with the Dow Jones up more than 400 points on Friday. The Dow was up 1.34% to...
Barclays Analyst Paul Kearney has repeated a balance assessment on the shares of G-III Garment Group Ltd GIII and reduced the price target from...
Needham updated Penumbra Inc PEN Buy from hold with a price target of $244. The analyst notes that management has indicated that PEN...
Mizuho analyst John J. Baumgartner confirmed the buy recommendation on the shares of Kraft Heinz Co KHC with a target price of $48.00. ...
Transaction in treasury shares 09.09.2022 • • • • • • • • • • • • • • • Shell plc (the “Company”)...
Mizuho Analyst Vijay Rakesh repeated a purchase and $225 target price Nvidia Corp NVDA. Mizuho hosted NVDA’s VP of Accelerated Computing, Ian Buck, and...
Mortgage rates are at their highest since the Great Recession as housing affordability continues to fall, the study finds Freddie Mac FMCC Data. The...
Mizuho Analyst Vijay Rakesh repeated a purchase on Broadcom Inc AVGO and a price target of $725 reflecting technology leadership with Tomahawk 4/5, growing...
Electric Vehicle Company Fisker Inc FSR could be in the spotlight for investors with strong reservation numbers and late 2022 production. A recent interview...
AstraZeneca plc AZN and Merck & Co Inc MRK announced long-term follow-up results from the Phase 3 PAOLA-1 and SOLO-1 studies in the first-line...